No effects on insulin sensitivity but diverging effects on serum free fatty acid concentrations by addition of seafood products containing either n-3 or n-6 fatty acids

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 8, Issue 3, 1998, Pages 145-153

  Gustafsson, I B ^a   Ohrvall M ^a   Ekstrand, B ^a   Vessby, B ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Fish oil; Insulin sensitivity; N 3 fatty acids; N 6 fatty acids; Seafood; Serum free fatty acids; Serum lipids

Indexed keywords

EID: 0002713354     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Dyerberg J, Bang HO, Stoffersen E, Moncade S, Vane JR (1978) Eisapentaenoic acid in prevention of thrombosis and atherosclerosis? Lancet 2:117-119
2. Burr ML, Gilbert JF, Holliday RM, Elwood PC, Fehily AM, Rogers S, Sweetnam PM, Deadman NM (1989) Effects of changes in fat fish and fibre intake on death and myocardial reinfarction: Diet and reinfarction trial. Lancet 12:757-761
3. Kromhout D, Bosschieter EB, Coulander CL (1985) The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 19:1205-1209
4. Norell SE, Ahlbom A, Feychting M, Pedersen NL (1986) Fish consumption and mortality from coronary heart disease. Br Med J 293:426
5. Shekelle RB, Missell LV, Paul O, Shryrock AM, Stamler J (1985) Fish consumption and mortality from coronary heart disease. N Engl J Med 313: 820
6. Vollset SE, Hench J, Bjelke E (1985) Fish consumption and mortality from coronary heart disease. N Engl J Med 313: 820-821
7. Curb JD, Read DM (1985) Fish consumption and mortality from coronary heart disease. N Engl J Med 313: 821-822
8. Harris WS (1985) Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 30: 785-807
9. Budowski P (1981) Review: Nutritional effects of ω-polyunsaturated fatty acids. Isr J Med Sci 17: 223-231
10. Schmidt EB, Kristensen SD, De Caterina RI, Illingworth DR (1993) The effect of n-3 fatty acids on plasma lipoproteins and other cardiovascular risk factors in patients with hyperlipidemia. Atherosclerosis 103: 107-121
11. Morris MC, Sack SF, Rosner B (1993) Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 88: 523-533
12. McManus RM, Jumpson J, Finegood DT, Clandinin MT, Ryan EA (1996) A comparison of the effects of n-3 fatty acids from linseed oil, and fish oil in well controlled type 11 diabetes. Diabetes Care 19: 463-467
13. Annuzzi G, Rivellese A, Capaldo B, Di Mariono L, Iovine C, Marotta G, Riccardi G (1991) A controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients. Atherosclerosis 87: 65-73
14. Herrmann W, Biermann J, Ratzmann KP, Lindhofer HG (1992) Effect of fish oil concentrate on lipoprotein profile of patients with type II diabetes mellitus. Med Klin 87: 12-15
15. Rivellese AA, Maffettone A, Iovine C, Di Marino L, Annuzzi G, Mancini M, Riccardi G (1996) Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Diabetes Care 19: 1207-1213
16. Goh YK, Jupmsen JA, Ryan EA, Clandinin MT (1997) Effect of omega 3 fatty acid on plasma lipids, cholesterol and lipoprotein fatty acid content in NIDDM patients. Diabetologia 40: 45-52
17. Schindler OS, Rost R (1996) Effect of low dose omega-3 fatty acid supplementation on plasma lipids and lipoproteins in coronary patients with dyslipoproteinemia. Z Ernahrungswiss 35: 191-198
18. Rambjor GS, Walen AI, Windsor SL, Harris WS (1996) Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans. Lipids 31 (Suppl.) S45-S49
19. Gustafsson I-B, Öhrvall M, Ekstrand B, Vessby B (1996) Moderate amounts of n-3 fatty acid enriched seafood products are effective in lowering serum triglycerides and blood pressure in healthy subjects. J Hum Nutr Diet 9: 135-145
20. Havel RJ, Eder HA, Bragdon JH (1955) The determination and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345-1353
21. Seigler L, Wu WT (1981) Separation of serum high-density lipoprotein for cholesterol determination: ultracentrifugation vs precipitation with sodium phosphotungstate and magnesium chloride. Clin Chem 27: 838-841
22. Da Col P, Kostner GM (1983) Immunoquantification of total apolipoprotein B in serum by nephelometry: Influence of lipase treatment and detergents. Clin Chem 29: 1045-1050
23. Boberg M, Croon L-B, Gustafsson I-B, Vessby B (1985) Platelet fatty acid composition in relation to fatty acid composition in plasma and to serum lipoprotein lipids in healthy subjects with special reference to the linoleic acid pathway. Clin Sci 1875: 581-587.
24. Öhrvall M, Tengblad S, Vessby B (1993) Lower tocopherol serum levels in subjects with abdominal adiposity. J Intern Med 234: 53-60
25. Thurnham DI, Davies JA, Crump BJ, Situnayake RD, Davis M (1986) The use of different lipids to express serum tocopherol:lipid ratios for the measurement of vitamin E status. Am Clin Biochim 23: 514-520
26. Öhrvall M, Tengblad S, Ekstrand B, Siegbahn A, Vessby B (1994) Malondialdehyde concentration in plasma is inversely correlated to the proportion of linoleic acid in serum lipoprotein lipids. Atherosclerosis 108: 103-110
27. Boehringer Mannheim GmbH Diagnostic (1989) Enzymun-Test Insulin. Enzyme immunological test for the quantitative determination of human insulin in vitro.
28. Hjelm M, de Verdier CH (1963) A methodological study of the enzymatic determination of glucose in blood. Scand J Clin Lab Invest 15: 415-428
29. De Fronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: 214-223
30. Jones B, Kenward MG (1989) Design and analysis of cross-over trials. Chapman and Hall, London, New York
31. Harris WS (1989) Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 30: 785-807
32. Rassia SG, Kestin M, Nestel PJ (1991) Linoleic acid lowers LDL-cholesterol without a proportionate displacement of saturated fatty acids. Eur J Clin Nutr 45: 315-320
33. Mensink RP, Katan MB (1992) Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 12: 911-919
34. Vessby B, Gustafsson I-B, Boberg J, Karlström B, Lithell H, Werner I (1980) Substituting polyunsaturated for saturated fats as a single change in a Swedish diet: effects on serum lipoprotein metabolism and glucose tolerance in patients with hyperlipoproteinemia. Eur J Clin Invest 120: 193-202
35. Brussard JH, Dallinga-Thie G, Groot PHE, Katan MB (1980) Effects of amount and type of dietary fat on serum lipids, lipoproteins and apolipoproteins in man: A controlled 8-week trial. Atherosclerosis 36: 515-517
36. Vessby B (1993) Dietary supplementation with n-3 fatty acids in type 2 diabetes. Ann N Y Acad Sci 683: 244-249
37. Popp-Snijders C, Schouten JA, Heine RJ, van der Meer J, van der Veen EA (1987) Dietary supplementation of ω-3 polyunsaturated fatty acids improves insulin sensitivity in non-insulin-dependent diabetes. Diabetes Res 4: 141-147
38. Eritsland J, Seljeflot I, Abdelnoor M, Arnesen H, Torjesen PA (1994) Long-term effects of n-3 fatty acids on serum lipid and glycaemic control. Scand J Clin Lab Invest 54: 273-280
39. Karats D, Dabach Y, Hollander G, Ben-Naim M, Schwarte R, Berry EM, Stein O, Stein Y (1991) Fish oil ingestion in smokers enhances peroxidation of plasma lipoproteins. Atherosclerosis 90: 127-139
40. Meydani M, Natiello F, Goldin B, Free N, Woods M, Schaefer E, Blumberg IB, Gorbach SL (1991) Effect of long-term fish oil supplementation on vitamin E status and lipid peroxidation in women. J Nutr 121: 484-491